Updating targets for natural killer/T-cell lymphoma immunotherapy
Updating targets for natural killer/T-cell lymphoma immunotherapy
About this item
Full title
Author / Creator
Publisher
China: Chinese Anti-Cancer Association (CACA), Cancer Biology & Medicine
Journal title
Language
English
Formats
Publication information
Publisher
China: Chinese Anti-Cancer Association (CACA), Cancer Biology & Medicine
Subjects
More information
Scope and Contents
Contents
Natural killer/T-cell lymphoma (NKTCL) is a highly invasive subtype of non-Hodgkin lymphoma, typically positive for cytoplasmic CD3, CD56, cytotoxic markers, including granzyme B and TIA1, and Epstein-Barr virus (EBV). The current treatment methods for NKTCL are associated with several drawbacks. For example, chemotherapy can lead to drug resistanc...
Alternative Titles
Full title
Updating targets for natural killer/T-cell lymphoma immunotherapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2488702300
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2488702300
Other Identifiers
ISSN
2095-3941
DOI
10.20892/j.issn.2095-3941.2020.0400
